Page 86 - Comstock Act News Today

Since the Supreme Court overturned Roe, abortion has been the deciding issue in ensuing elections, National Organization for Women President Christian F. Nunes writes in an opinion column.

We already know two things: No matter how long it takes, antiabortion advocates will keep sending up cases and seeing what sticks, just as they did in attacking Roe v. Wade. And no matter what happens with mifepristone, this Supreme Court is not done with abortion just yet.

The Supreme Court has preserved full access to mifepristone, a key abortion medication, while a lower court considers whether to restrict when and how the drug should be prescribed.

Getting out of the fray over abortion is proving easier said than done for the U.S. Supreme Court. The recent showdown over the abortion pill mifepristone offers a glimpse of

As the Republican Party keeps radicalizing, Democrats need to elevate reproductive freedom.

The recent showdown over the abortion pill mifepristone offers a glimpse of the legal fights likely to land at the US Supreme Court in coming years. Brewing debates over travel restrictions, emergency hospital procedures, and mail delivery of drugs threaten to make abortion a recurring part of the court’s docket.

North Carolina remains both a safe haven and on the target list.

The Supreme Court stayed a federal district court order that suspended the FDA's approval of the drug mifepristone, which is used as part of a two-drug regimen to induce abortion. The Supreme Court’s decision returns mifepristone access to the status quo for the time being.

 

A Supreme Court decision keeps the abortion pill mifepristone widely available, for now.